HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo.

Abstract
We previously showed that (5S)-5-hydroxy-7-(4-hydroxyphenyl)-1-phenylhept-3-one (AO-0011) and (5S)-5-methoxy-1,7-diphenylhept-3-one (AO-0016) isolated from Alpinia officinarum exhibited stronger anti-influenza virus activity and anti-respiratory syncytial virus (RSV) activity, respectively, than the other isolated diarylheptanoids. In this study, we synthesized an enantiomer (AO-0503) and racemate (AO-0504) of AO-0011 and an enantiomer (AO-0514) of AO-0016. The anti-RSV activities of the three stereoisomers (AO-0503, AO-0504, and AO-0514) and AO-0011 were examined in vitro and in vivo to evaluate the stereoisomeric effect on anti-RSV activity. In a plaque reduction assay using human epidermoid carcinoma cells, all four diarylheptanoids significantly exhibited anti-RSV activity, and AO-0514 and AO-0016 exhibited stronger anti-RSV activity than AO-0503, AO-0504, and AO-0011. In a murine RSV infection model, all four diarylheptanoids with anti-RSV activity in vitro were also significantly effective in reducing virus titers in the lungs of RSV-infected mice. In the histopathological analysis of RSV-infected lungs, the oral administration of even AO-0514, which showed the lowest reduction of virus titers in the lungs, was significantly effective in reducing the infiltration of lymphocytes and in reducing the interferon-γ level, which is a marker of severity of pneumonia due to RSV infection, in bronchoalveolar lavage fluids prepared from RSV-infected mice. Although the stereoisomeric effects of diarylheptanoids on anti-RSV activity varied moderately, all four diarylheptanoids examined were suggested to ameliorate pneumonia and have a potential anti-RSV activity in vivo. They are possibly mother compounds for the development of an anti-RSV drug in the future.
AuthorsKatsuhiko Konno, Motofumi Miura, Masaharu Toriyama, Shigeyasu Motohashi, Rie Sawamura, Wataru Watanabe, Hiroki Yoshida, Masahiko Kato, Ryuichi Yamamoto, Ken Yasukawa, Masahiko Kurokawa
JournalJournal of natural medicines (J Nat Med) Vol. 67 Issue 4 Pg. 773-81 (Oct 2013) ISSN: 1861-0293 [Electronic] Japan
PMID23344928 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Diarylheptanoids
  • Interferon-gamma
Topics
  • Alpinia (chemistry)
  • Animals
  • Antiviral Agents (chemistry, pharmacology, therapeutic use)
  • Cell Line, Tumor
  • Diarylheptanoids (chemistry, pharmacology, therapeutic use)
  • Female
  • Humans
  • Interferon-gamma (metabolism)
  • Lung (pathology, virology)
  • Mice
  • Mice, Inbred BALB C
  • Respiratory Syncytial Virus Infections (drug therapy, pathology)
  • Respiratory Syncytial Viruses (drug effects)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: